|
Background
In the 2018 Budget, the Hong Kong Special Administrative Region Government set aside $500 million to set up the Chinese Medicine Development Fund (Fund), which is supervised by the Health Bureau. The fund was officially put into operation in June 2019.
Objectives and participants
The main purpose of the Hong Kong Chinese Medicine Development Fund is to promote the development of the Chinese medicine and Chinese medicine drug sectors, enhance the overall standard of the industry, nurture talents for Chinese medicine, promote Chinese medicine-related research and enhance public knowledge and understanding of Chinese medicine. The Fund will benefit practitioners and organizations at different levels of the Chinese medicine and Chinese medicine drug sectors including Chinese medicine practitioners (covering both registered and listed Chinese medicine practitioners), related healthcare professionals and persons engaged in the Chinese medicine drug industry. Organizations include Chinese medicine clinics, manufacturers and wholesalers of proprietary Chinese medicine (pCM) , retailers and wholesalers of Chinese herbal medicine, as well as professional bodies, trade associations, institutions related to Chinese medicine, universities and higher education institutions.
Content
The Chinese Medicine Development Fund comprises of two parts, namelythe Enterprise Support Scheme (ESP) and the Industry Support Scheme (ISP). There are four funding schemes under ESP, including funding scheme for "Chinese Medicine Personal Training and Chinese Medicine Clinic Improvement Funding Scheme", the "Proprietary Chinese Medicine Quality and Manufacturing System Enhancement Funding Scheme", the "Proprietary Chinese Medicine Registration Supporting Scheme" and the "Chinese Medicine Warehouse Management, Logistics and Services Improvement Funding Scheme". The ISP is divided into two projects, including "Chinese Medicine Industry Training Funding Scheme & Chinese Medicine Promotion Funding Scheme" and the "Chinese Medicine Applied Studies and Research Funding Scheme".
Advisory Committee
The Committee, for which the Chairman and members are appointed by the Secretary for Health, is comprised of representatives from various sectors, including Chinese medicine practitioners, Chinese medicine drugs, healthcare/ integrated Chinese and Western medicine, academics, testing and certification, as well as laypersons with extensive experience in funding operations, financial management, public education and promotions. The appointments will take effect from March 1, 2023, to February 28, 2025, for a term of two years.
Membership of the Committee is as follows:
|
Chairman |
Members |
Ex-officio Members |
|
Professor SO Cheung-tak Douglas, BBS, JP
|
Mr AU Ho-ting
Professor BIAN Zhaoxiang, MH
Dr CHAN Kei-wai
Mr CHAN Wing-suen
Mr CHUNG Wai-lim, William
Professor FENG Yibin
Mr HUI Leung-wah, Herbert
Mr LAM Kar-yeung
Ms LAM Pui-yan
Ms LAU Sze-wan, Serena, MH, JP
Mr LEE Kai-ping, Henry
Miss LEE Yan-kwan, Anita
Mr LI Hin-yeung
Mr LING Kwan-yee
Dr LIONG Ching
Mr MA Kwai-yung, Gerry, JP
Dr OR Ka-hang
Dr SO Tsz-him
Miss Suen Wai-lam
Dr TAM Tin-lok, Timothy
Mr TANG Man-chun, Sky
Ms TANG Wai-man, Vivian
Ms WANG Huimin
Mr WONG Ka-on
Professor WU Che-yuen, Justin
|
Representative(s) from the Health Bureau
Representative(s) from the Department of Health
Representative(s) from the Hospital Authority
Representative(s) from the Innovation and Technology Commission
|
Implementation Agent
The Hong Kong Productivity Council will be serving as the Implementation Agent.
Contact us
HKPC building, 78, Tat Chee Avenue, Kowloon Tong
Tel：2788 5632 (General Enquiries) 2788 5633 (Chinese Medicine Personal Training Funding Scheme A1-1, A1-2, A1-3)
Fax：3187 4581
Email：enquiry@cmdevfund.hk
Website：www.CMDevFund.hk
Facebook：https://www.facebook.com/102635199200136/
|
